Actively Recruiting
Development and Validation of an Anxiety Disorder Prediction Model for Premature Ejaculation Patients
Led by Xijing Hospital · Updated on 2024-11-07
700
Participants Needed
2
Research Sites
109 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Background: Premature ejaculation (PE) is a common sexual dysfunction that can significantly impact the quality of life and psychological well-being of affected individuals. Anxiety disorders, often comorbid with PE, exacerbate symptoms and complicate treatment outcomes. There is a critical need for a reliable prediction model to identify patients at risk of developing anxiety disorders associated with PE. Objective: The primary aim of this study is to develop and validate a predictive model that accurately identifies premature ejaculation patients who are at high risk of developing anxiety disorders. The model will be designed to facilitate early intervention strategies and improve patient outcomes. Methods: This prospective observational study will enroll male patients diagnosed with PE from multiple clinical centers. Participants will undergo comprehensive assessments including validated questionnaires, clinical interviews, and medical history reviews to collect baseline data on potential predictors of anxiety disorders. Machine learning algorithms will be utilized to analyze the collected data and derive a predictive model. External validation will be conducted using a separate cohort of patients not involved in the initial model development phase. Outcome Measures: The primary outcome measure will be the accuracy of the predictive model in identifying patients who subsequently develop anxiety disorders within a predefined follow-up period. Secondary outcomes include evaluating the model's sensitivity, specificity, positive predictive value, and negative predictive value. Significance: Successful development and validation of this prediction model could lead to improved patient care through targeted interventions and personalized treatment plans for those at risk of anxiety disorders related to PE. This research may also contribute to a better understanding of the complex interplay between sexual dysfunction and mental health.
CONDITIONS
Official Title
Development and Validation of an Anxiety Disorder Prediction Model for Premature Ejaculation Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Meet the international medical criteria for premature ejaculation diagnosis
- Identify as heterosexual and engage in vaginal intercourse
- Be in a stable, monogamous relationship
- Have an International Index of Erectile Function-5 score of 17 points or higher
- Understand the study purpose, agree to participate, and sign informed consent
You will not qualify if you...
- Under 18 years of age
- Identify as gay or bisexual
- Judgment of premature ejaculation based only on masturbation or non-vaginal intercourse
- Premature ejaculation self-assessment scale score of 8 points or lower
- Have diseases that may affect anxiety symptoms such as hyperthyroidism, hypothyroidism, digestive diseases, or malignant tumors
- Have taken anti-anxiety or premature ejaculation drugs within the past 2 months
- History of severe neurological diseases like epilepsy or mental disorders such as schizophrenia or bipolar disorder
- Poor cooperation during diagnostic interviews
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Xi'an Daxing Hospital affiliated to Yan'an University
Xi'an, Shaanxi, China, 710016
Actively Recruiting
2
Xijing Hospital
Xi'an, Shaanxi, China, 710032
Actively Recruiting
Research Team
J
Jianlin Yuan, Doctor
CONTACT
Z
Zhaoqing Li, bachelor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here